Natco Pharma, Hetero seek marketing authorisation for anti-Covid drug molnupiravir, Health News, ET HealthWorld
Hyderabad-based Natco Pharma Limited and Hetero have sought marketing authorisation for their anti-Covid drug molnupiravir from the drug regulator, people in the know told ET. The Subject Expert Committee (SEC)…

